retatrutide fat loss study Results After 40: Realistic Timelines ✨ NOW OFFERING RETATRUTIDE ✨

Food tolerance improves dramatically after week 12 for most patients

In addition to greater weight loss, participants who took either dose of orforglipron recorded lower average blood sugar levels at the end of the trial than either dose of semaglutide

More than one in eight patients on retatrutide were completely free of knee pain by the end of the trial an outcome with meaningful implications for patients whose joint pain is driven or worsened by excess weight

Retatrutide adds glucagon receptor activation to the mix, which drives additional lipolysis and energy expenditure beyond what GLP-1 and GIP agonism provide alone

Further Reading For additional peer-reviewed research, see: FDA warning letter process

Vitamin D and calcium are critical for muscle contraction and bone health